Diffusion Pharmaceuticals
DFFN
#10331
Rank
NZ$15.01 M
Marketcap
NZ$7.36
Share price
10.28%
Change (1 day)
-36.83%
Change (1 year)

Earnings for Diffusion Pharmaceuticals (DFFN)

Earnings in 2023 (TTM): -NZ$21.37 Million

According to Diffusion Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -NZ$26.08 Million, an increase over its 2021 earnings that were of -NZ$41.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Diffusion Pharmaceuticals from 1999 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$21.37 Million-18.08%
2022 -NZ$26.08 Million-36.46%
2021 -NZ$41.05 Million54.72%
2020 -NZ$26.53 Million38.32%
2019 -NZ$19.18 Million-39.03%
2018 -NZ$31.46 Million677.09%
2017 -NZ$4.05 Million-86.85%
2016 -NZ$30.78 Million-22.75%
2015 -NZ$39.85 Million38.74%
2014 -NZ$28.72 Million598.54%
2013 -NZ$4.12 Million-57.56%
2012 -NZ$9.69 Million-62.43%
2011 -NZ$25.79 Million58.75%
2010 -NZ$16.25 Million238.41%
2009 -NZ$4.8 Million189.55%
2008 -NZ$1.66 Million1576.75%
2007 -NZ$0.1 Million-35.01%
2006 -NZ$0.16 Million
1999 -NZ$12.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.25 Billion 1,031.69%๐Ÿ‡บ๐Ÿ‡ธ USA